mirtazapine has been researched along with T-Lymphocytopenia, Idiopathic CD4-Positive in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
T-Lymphocytopenia, Idiopathic CD4-Positive: Reproducible depletion of CD4+ lymphocytes below 300 per cubic millimeter in the absence of HIV infection or other known causes of immunodeficiency. This is a rare, heterogeneous syndrome and does not appear to be caused by a transmissible agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, D | 1 |
| Mehta, A | 1 |
| Shetty, N | 1 |
| R, P | 1 |
| Javali, M | 1 |
| T Acharya, P | 1 |
| Srinivasa, R | 1 |
1 other study available for mirtazapine and T-Lymphocytopenia, Idiopathic CD4-Positive
| Article | Year |
|---|---|
Idiopathic CD4 lymphocytopenia in neurological disorders.
Topics: Adult; Biopsy; Brain; CD4 Lymphocyte Count; Fatal Outcome; Female; Humans; Magnetic Resonance Imagin | 2020 |